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SUMMARY 
 
Aim: The experts have argued about the use of the risk, injury, failure, loss and end-
stage renal failure (RIFLE) criteria as a prognosis scoring system. We examined the 
association between in-hospital mortality and the RIFLE criteria, and discussed its 
accuracy as a prognosis factor. 
 
Methods: In this prospective study, we analysed the data gathered from a cohort of 956 
patients admitted in a Spanish tertiary hospital between January 1998 and April 2006. 
Hazard ratios for mortality, and survival curves within 60 days were calculated. 
Discrimination and calibration of the model were also assessed. 
 
Results: Excluding 53 patients, 903 patients were finally analysed. We classified them 
into groups according to the maximum RIFLE class reached during their admission. The 
RIFLE class was assessed by the glomerular filtration rate criterion. We found an 
increase in the in-hospital mortality risk. Cox proportional hazard models showed that 
RIFLE classes risk, injury, and failure were significant predictive factors (hazard ratios 
were 2.77, 3.23 and 3.52, respectively; P for trend was 0.005). The multivariate 
analyses from the cross-classification of the participants according to Liano score values 
(severity of illness) and RIFLE classes showed additive effects of the exposures on in-
hospital mortality. 
 
Conclusion: In this population, the risk of in-hospital mortality during the acute kidney 
injury (AKI) episode was positively associated with RIFLE classes. We showed that the 
RIFLE classification system had discriminative power in predicting hospital mortality 
within 60 days in AKI patients, but not better than a specific AKI predictive model. 
However, a combined use of both may give a more robust prognosis system. 
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INTRODUCTION 
 
Acute kidney injury (AKI) is an increasingly common syndrome.1–3 Although a 
decrease in mortality has been reported using administrative databases,1,2 the lack of 
detailed clinical and laboratory information, and the existence of changing coding 
practices limits the interpretation.3 Moreover, clinical reports and reviews continue 
reporting high mortality rates,4–8 despite advances in medical care. These mortality rates 
vary widely based on the type of clinical setting, and due to the differences of AKI 
definitions. 
More than 30 different definitions of AKI have been published to date,9 thus making 
both research and clinical work difficult. The Acute Dialysis Quality Initiative (ADQI) 
developed a consensus definition of AKI: the risk, injury, failure, loss and end-stage 
renal failure (RIFLE) criteria.9 The RIFLE criteria provides a graded classification of 
AKI severity (risk, injury and failure), corresponding the final two stages to clinical 
outcomes. This unified definition could prove useful in conducting better-designed 
clinical research in the form of patient stratification, centre-to-centre comparisons, as 
well as assessing new interventions.10
The use of RIFLE as a classification system warrants worldwide clinical validation 
before applying the criteria to a clinical setting. Furthermore, such an approach is 
specifically more relevant when there are apparent controversies surrounding this issue. 
On one hand, Maccariello et al.11 evaluated the RIFLE classification and outcomes in a 
cohort of critically ill patients, and Joannidis gave his support to it in an associated 
editorial.12 On the other hand, Bellomo et al.13 and Kellum et al.14 have expressed their 
concerns about the misuse and misinterpretation of the RIFLE criteria that, in their 
opinion, the previous articles showed. They recommended that the RIFLE classification 
should not be used as a prognostic scoring system, and that the RIFLE classification 
should not be used at a single moment in time, as Maccariello did. 
Because we consider these topics of interest, the objective of this study was to evaluate 
what association may exist between the RIFLE criteria and in-hospital mortality, as well 
as to examine the predictive capacity of the RIFLE criteria. We think this work can shed 
some light on these current issues. 
 
 
 
METHODS  
 
Study population 
We conducted this prospective observational study between January 1998 and April 
2006 at the University Hospital of Navarra, in the city of Pamplona, Spain. This is a 
400-bed tertiary care teaching centre. During this period, 988 cases in 956 admitted 
patients who had had a nephrology consultation requested, because of suspicion of AKI, 
were prospectively entered into a computerized database. We excluded patients who: (i) 
presented with oliguria but did not show an adequate serum creatinine increase to 
qualify for one of the creatinine RIFLE criteria (n = 44); (ii) were younger than 16 years 
(n = 1); or (iii) had missing data (n = 8). In the event of multiple admissions (32 cases), 
only the initial admission was considered to avoid bias. Therefore, 903 patients 
remained for further analysis. The hospital ethics committee approved the study. 
 
 
 
Data collection and definitions 
The following demographic and clinical data were collected at the time of nephrology 
consultation: age, gender, current Liano score and the elements of the equation,15,16 
Karnofsky score17 at home, admission type (surgical or medical), presence of oncology 
disease or not, previous history of chronic renal failure, occurrence of diabetes or not, 
aetiology of AKI (pre-renal, renal, post-renal, and other causes), and prior food intake. 
In addition, information such as subsequent treatment, or further examination of serum 
creatinine levels were ascertained. Finally, whether the patients died within 60 days 
after the start of the nephrology consultation was also noted. 
To obtain the Liano score, the following equation was used:15 0.032 x age in decades - 
0.086 x male gender - 0.109 x nephrotoxic + 0.109 x oliguria + 0.116 x hypotension + 
0.122 x jaundice + 0.150 x coma - 0.154 x consciousness + 0.182 x assisted respiration 
+ 0.210. 
We classified all the in-patients according to the highest RIFLE category during the 
hospital admission (i.e. risk, injury and failure).9 Those patients who presented with 
neither oliguria nor adequate increase of serum creatinine were included in the ‘no AKI’ 
group. However, we did not study the outcome classes of RIFLE (i.e. loss and end-stage 
kidney disease). 
We calculated the baseline creatinine in patients with no previous history of chronic 
renal disease using the modification of diet in renal disease (MDRD) equation,18 as 
recommended by the ADQI,9 assuming a glomerular filtration rate of 75 mL/min per 
1.73 m2. For patients with a known history of chronic renal disease, the baseline serum 
creatinine was assumed to be the one that was measured at the time of hospital 
admission. 
Food intake was defined as the caloric ingestion in the previous days, and this was 
classified as ‘appropriate’ when it was optimal, ‘mild malnutrition’ when it had been 
inadequate for less than 3 days, ‘moderate malnutrition’ when it had been inadequate 
between 3 and 7 days, and ‘severe malnutrition’ when it had been inadequate for more 
than 7 days. 
All cases were treated during the admission by the same nephrologist, and all the data 
were gathered by the same observer. 
The primary outcome variable was in-hospital mortality within 60 days. 
 
Statistical analysis 
Continuous data were presented as medians (and interquartile ranges), and compared via 
ANovA. Categorical variables were expressed as proportions and compared using 
Fisher’s exact test. 
Cox proportional hazards models were fitted to assess the relationship between RIFLE 
categories (no evidence of AKI, risk (R), injury (I) and failure (F)) and the risk of in-
hospital mortality. The time of origin was the date when the nephrology consultation 
started. The event defined was death, whereas those cases alive at the end of follow up 
and those lost to follow up were censored at their last observation. Hazard ratios (HR) 
and their 95% confidence intervals (CI) were calculated considering the group with no 
AKI as the reference category. We fitted a crude model (univariate; i.e. without any 
adjustment), an age and gender model, and a multivariate adjusted model including the 
following variables selected by the descriptive analysis of potential confounders: Liano 
score, prior food intake, need for renal replacement therapy, chronic renal failure, the 
cause of AKI, admission type (surgical or not) and Karnofsky score. We additionally 
adjusted for oncologic disease because of a higher proportion of oncology patients in 
our cohort (37%). We calculated P for trend considering RIFLE categories as a 
continuous variable. 
We analysed overall survival at 60 days across groups using the Kaplan–Meier 
methods, and tested differences between groups using the log–rank test. 
Calibration of the model was assessed by the goodness-of-fit statistic test from Hosmer–
Lemeshow, and graphically displayed by plotting observed and predicted mortality for 
all patients across all risk ranges. Discrimination power was evaluated by determining 
the area under the receiver–operating curve (ROC). 
We conducted additional multivariate analyses to assess the joint effects of a low/high 
Liano score, considering the median value (0.22) as a cut-off, and the categories of 
RIFLE (no AKI or R vs category I or F), categorizing the participants in four (two x 
two) different groups. We combined RIFLE groups to maintain enough statistical power 
with the cross-classification categories because of the relatively small number of 
patients in our study. 
In addition, we performed a joint score, combining both RIFLE categories and Liano 
score. We added to the Liano score the probability of death derived from the non-
conditional logistic model for RIFLE I or F categories, using the following equation: 
 
P = (exp(−2.294 + 1.503 x I or F)) / (1 + exp(−2.294 + 1.503 x I or F)). 
 
It was based on the fact that P = odds/(1 + odds). 
All P-values presented are two tailed; P < 0.05 was considered statistically significant. 
Statistical analyses were conducted using SPSS v.13.0 (SPSS Software, Chicago, IL, 
USA). 
  
 
 
RESULTS 
 
The four RIFLE groups differed in gender, admission type, proportion of oncology 
patients, pre-existing chronic renal failure, severity of illness (measured as Liano score), 
functional status at home (measured as Karnofsky score), prior food intake, causes of 
acute renal failure (ARF) and the further need for renal replacement therapy (Table 1). 
The mortality rate in the no AKI group was 4.2%. In contrast, there was an increase 
from 20.5% in class R, 27.0% in class I to 33.4% in the class F. 
The adjusted multivariate analyses (Table 2) showed that the RIFLE classes R, I and F 
were independent significant predictors of hospital mortality within 60 days. Patients in 
the risk (R) class had a HR of 2.77 (95% CI, 1.15–6.66). Patients with injury (I) had a 
HR of 3.23 (95% CI, 1.42–7.37), while those with failure (F) had a HR of 3.52 (95% 
CI, 1.59–7.80). We recalculated HR with group R as the reference group, excluding 
those in the no AKI group. This examined whether R, I and F classification might be 
really useful in terms of predicting the risk. Unfortunately, neither group I nor F showed 
any significant adjusted HR for mortality, at 1.15 (95% CI, 0.63–2.09) and 1.22 (95% 
CI, 0.69–2.17), respectively. 
We found additive effects of the exposures on in-hospital mortality from the cross-
classification of the participants according to their Liano score values (median as a cut-
off, 0.22) and RIFLE classes (Fig. 1). In other words, for any degree of AKI, hospital 
mortality increased as the Liano score increased. At the same time, patients with similar 
Liano scores but with more severe AKI had higher mortality rates. 
Cumulative survival rates within 60 days after starting the nephrology consultation 
differed significantly between groups (Fig. 2), consistent with our previous findings. 
The calibration curve shows that the proportion of patients who died increased in 
accordance with the increase in the severity of AKI. However, the result of the Hosmer– 
Lemeshow goodness-of-fit test was statistically significant (P = 0.016), indicating a 
poor calibration ability (Fig. 3). That means that the predicted probabilities did not 
closely reflect the real risk. 
The area under the ROC for the RIFLE criteria was smaller than the one for the Liano 
score, and the latter was smaller than the RIFLE criteria and Liano score combined (Fig. 
4). 
 
 
DISCUSSION 
 
This study involved a cohort of 903 patients admitted to a tertiary-care academic 
medical centre and sought to examine the ability of the RIFLE criteria to predict in-
hospital mortality within 60 days. 
We showed a significant increase of mortality associated with an increasing severity of 
AKI, as defined by the RIFLE criteria in this population. These findings are consistent 
with published reports19,20 and, more interestingly, the mortality rates were very similar 
to those recently reported by Bagshaw.21
Figure 2 shows a clear trend between RIFLE and the mortality. However, this trend is 
substantially reduced when adjusting for the potential confounding factors as shown in 
Table 2. We found that Liano score was the most important confounding factor. When 
adjusting for Liano score, it could explain the main magnitude reduction in the HR we 
obtained. 
As several experts involved in the development of the RIFLE consensus have expressed 
their concerns about the misuse of the RIFLE criteria as a prognostic score system,14 our 
results should be interpreted with caution. The RIFLE criteria was not formulated to 
provide precise and robust prognosis information. AKI-specific predictive models, such 
as the Liano score, are more accurate for this purpose. Nonetheless, there is evidence 
showing an increase in mortality risk with a small increment in serum creatinine 
levels.22
We calculated the cumulative survival rates according to recommendations for optimal 
follow-up time in patients with established ARF.9,23 Mortality related to other causes 
could bias any extended follow up. 
With reference to the area under the ROC, the conventional threshold of 0.7 is 
considered satisfactory for clinical use.24 Logically, the Liano score proved to have a 
better discriminatory power than the RIFLE criteria. Comparing the RIFLE criteria with 
the Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential 
Organ Failure Assessment (SOFA) scores, authors have found similar conclusions after 
analysing an intensive care unit population.25 However, a combined use of both RIFLE 
criteria and Liano score to perform a new model proved the best discriminatory power. 
Finally, the RIFLE criteria showed poor calibration ability, thus slightly 
underestimating in-hospital mortality.  
Our study also has some limitations. Urine output on a 6 h basis was not commonly 
measured in the wards, so we were unable to classify the patients according to this 
RIFLE criterion. Moreover, we started to collect the data before the whole definition 
was formulated. Besides, the exclusion of 44 oliguric patients without adequate serum 
creatinine increment might have changed the maximal classification.14 However, we 
believe that the influence of the misclassification of the diuresis variable would most 
likely have biased the HR toward the null value, reducing the magnitude of the risk 
estimates. The results remained statistically significant after adjusting for independent 
variables associated with mortality. A direct comparison of the predictive capacity of 
RIFLE criteria with and without the diuresis output might be needed to determine the 
importance of this value.12
Surprisingly, 44 patients from the original population presented oliguria but did not 
reach a minimum 50% increase in their serum creatinine levels. Furthermore, only 267 
patients (28.6%) from the cohort were oliguric. The interpretation of this finding is 
difficult with the available data, thereby leaving us with no possible explanation. 
However, we have minimized the influence of protein catabolism by grading the 
previous caloric consumption as well as adjusting for it in the analysis. Unfortunately, 
more accurate nutrition evaluation, such as serum prealbumin levels, was not measured 
in all patients. 
Some authors might argue against resolving the MDRD equation to extrapolate the 
serum baseline creatinine values in our population.12,26 According to the advice of 
ADQI9 and the methods in other studies,6,7,20,21 we used the MDRD equation for 
baseline creatinine values: it may underestimate the severity of ARF when using the 
RIFLE criteria. The Liano score is not as well known as other prognostic scoring 
systems, although it might prove quite useful. Nevertheless, our findings should 
encourage future researchers to study other severity scoring systems. 
Finally, because the study took place in a single hospital, our findings cannot be 
generalized to other centres. 
One of the strengths of our study is that patients were further stratified using a severity 
of illness score before analysis.20,27 We chose the Liano score because of its ability to 
discriminate mortality from survival and its ability to calibrate the observed mortality 
rate with the expected mortality in AKI patients.27–29 We also took into account the 
functional capacity in the analysis, because we consider that this factor may be 
independently associated with mortality.30
We want to point out that the joint effects of the Liano score and the RIFLE classes 
augmented the predictive powers. Perhaps this finding is the most interesting in our 
study, because the calculation of one complemented the value of the other. They could 
be used together in future practice to arrive at a more accurate predictive model. 
In conclusion, in this general hospital population, the risk of mortality during the AKI 
episode was positively associated with high RIFLE classes. We also showed that the 
RIFLE classification system had discriminative power in predicting hospital mortality 
within 60 days in AKI patients, but it was not better than a specific AKI predictive 
model. However, the combined use of both may give a more robust prognosis system 
that needs further investigation. 
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Table 1. Characteristics of 903 patients, according to each risk, injury, failure, loss and end-stage 
renal failure (RIFLE) category. 
 No AKI n = 259 
RIFLE R 
n = 112 
RIFLE I 
n = 185 
RIFLE F 
n = 347 P-value* 
Mortality (%) 4.2 20.5 27.0 33.4 <0.001 
Age, median years (IQR) 62 (19.75) 60 (20.25) 62 (18.00) 63 (18.00) 0.70 
Men (%) 72.8 73.7 69.1 69.1 0.24 
Surgical (%) 14.8 27.9 23.5 24.3 0.02 
Oncology patients (%) 40.2 44.9 35.1 32.6 0.02 
CRF (%) 65.9 26.3 12.0 28.0 <0.001 
Diabetic patients (%) 11.6 8.5 9.4 8.9 0.30 
Karnofsky score, median (IQR) 70 (20) 70 (20) 60 (10) 60 (10) <0.001 
Liano scoring, median (IQR) 0.16 (0.13) 0.19 (0.17) 0.25 (0.40) 0.30 (0.38) <0.001 
Oliguria (%) 0.0 16.1 34.6 52.0 <0.001 
Jaundice (%) 4.3 13.6 27.2 30.6 <0.001 
Coma (%) 1.1 5.9 14.1 18.0 <0.001 
Consciousness (%) 90.9 85.6 76.4 77.4 <0.001 
Mechanical ventilation (%) 1.1 9.3 27.2 25.7 <0.001 
Nephrotoxicity (%) 42.4 42.4 42.9 43.1 0.84 
Causes of AKI (%)     <0.001 
Pre-renal NA 80.5 81.1 68.8  
Intrinsic renal NA 16.9 15.7 22.0  
Post-renal NA 1.7 1.6 3.7  
Other causes NA 0.8 1.6 5.4  
Need of RRT (%) 1.8 11.9 24.6 41.4 <0.001 
Food intake (%)     <0.001 
Optimal nutrition 60.1 39.8 33.3 25.1  
Mild malnutrition 10.1 19.4 17.7 20.3  
Moderate malnutrition 19.7 16.3 25.9 32.6  
Severe malnutrition 10.1 24.5 23.1 22.0  
*P-value test with ANOVA test for continuous variables and Fisher’s exact test for categorical 
variables. AKI, acute kidney injury; CRF, chronic renal failure; F, failure; I, injury; IQR, interquartile 
range; NA, not applicable; R, risk; RRT, renal replacement therapy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 2. Incidence of in-hospital mortality, and hazard ratios and (95% confidence intervals) for             
in-hospital mortality according to each RIFLE category in 903 patients. 
 No AKI n = 259 
RIFLE R       
n = 112 
RIFLE I        
n = 185 
RIFLE F         
n = 347 
P for 
trend 
Incidence of in-hospital 
mortality, n (%) 11 (4.2) 23 (20.5) 50 (27.0) 116 (33.4) <0.001
Crude HR (95% CI) 1.00 (Ref.) 5.08 (2.19–11.76) 7.64 (3.56–16.37) 10.57 (5.13–21.79) <0.001
Age- and sex-adjusted 
HR (95% CI) 1.00 (Ref.) 5.07 (2.19–11.76) 7.67 (3.58–16.45) 10.57 (5.20–22.11) <0.001
Multivariate-adjusted 
HR† (95% CI) 1.00 (Ref.) 2.77 (1.15–6.66) 3.23 (1.42–7.37) 3.52 (1.59–7.80) 0.005 
†Adjusted for age, sex, Liano scoring, prior food intake, need of renal replacement therapy, chronic 
renal failure, cause of AKI, Karnofsky score, oncologic disease and admission type (surgical or not). 
AKI, acute kidney injury; CI, confidence interval; F, failure; HR, hazard ratios; I, injury; R, risk. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Adjusted hazard ratios (HR) for in-hospital mortality according to Liano score 
(LS) and risk, injury, failure, loss and end-stage renal failure (RIFLE) categories. HR 
were adjusted for age, sex, Liano score, prior food intake, need of renal replacement 
therapy, chronic renal failure, cause of acute kidney injury (AKI), Karnofsky score, 
oncologic disease and admission type (surgical or not). *P < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Sixty day survival after starting the nephrology consultation according to the 
RIFLE classes. Log–rank test, P < 0.01. AKI, acute kidney injury; F, failure; I, injury; 
R, risk. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Calibration curves for RIFLE criteria. The continuous diagonal line is the line 
of ideal prediction (predicted mortality = observed mortality) for RIFLE criteria (□). 
Calibration curves below the diagonal line indicate that actual mortality was greater 
than the predicted. AKI, acute kidney injury; F, failure; I, injury; R, risk. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Receiver–operator curve (ROC) analysis for RIFLE criteria, Liano score, and 
RIFLE criteria and Liano score combined. Area under the ROC for RIFLE criteria: 
0.69. Area under the ROC curve for Liano score: 0.78. Area under the ROC curve for 
RIFLE criteria and Liano score combined: 0.80. 
